Nurse Practitioner, Psychiatric/Mental Health · Hopkinsville, KY
NPI
1922482587
Since 2015
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
8
Medicare group memberships
Hospitals
0
Hospital affiliations
1100 S Main St
Hopkinsville, KY, 42240
Phone (270) 874-5131
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,679
79 services
Medicare patients, 2024
28
Average age 60
Drug cost, 2024
$3.3M
18,369 prescriptions
Company payments, 2025
$65K
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Hope R Smith prescribed most often to Medicare patients was Atorvastatin Calcium, with 638 prescriptions and refills. In total Hope R Smith wrote 18,369 Medicare prescriptions that cost $3.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 638 | 642 | 105 | $8,127 |
| Benztropine Mesylate Generic | 527 | 527 | 83 | $7,435 |
| Lisinopril Generic | 489 | 501 | 79 | $3,702 |
| Trazodone Hcl Generic | 482 | 493 | 100 | $6,207 |
| Quetiapine Fumarate Generic | 465 | 478 | 69 | $12K |
| Buspirone Hcl Generic | 453 | 457 | 84 | $11K |
| Risperidone Generic | 438 | 440 | 77 | $9,109 |
| Omeprazole Generic | 423 | 423 | 64 | $4,364 |
| Divalproex Sodium Generic | 392 | 394 | 59 | $19K |
| Olanzapine Generic | 375 | 377 | 63 | $22K |
| Metformin Hcl Generic | 371 | 373 | 64 | $2,608 |
| Levothyroxine Sodium Generic | 362 | 362 | 59 | $4,415 |
| Amlodipine Besylate Generic | 340 | 344 | 44 | $2,037 |
| Sertraline Hcl Generic | 333 | 335 | 56 | $3,253 |
| Rosuvastatin Calcium Generic | 322 | 322 | 37 | $18K |
Brand drugs: 2,328 claims; generic drugs: 15,964 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hope R Smith $65K ($65K in general payments such as food, travel and fees) from 14 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $50K.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 123 | $50K |
| Teva Pharmaceuticals USA, Inc. TEVA | 22 | $14K |
| Alkermes, Inc. ALKS | 18 | $309 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $236 |
| Vanda Pharmaceuticals Inc. VNDA | 14 | $231 |
| Abbvie Inc. ABBV | 13 | $151 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $84.95 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $83.97 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $61.71 |
| Corium, LLC | 3 | $55.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.